T. Rowe Price Associates’s LifeVantage LFVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$81K Sell
12,900
-5,334
-29% -$32.3K ﹤0.01% 3167
2026
Q1
$79K Hold
18,234
– – ﹤0.01% 3034
2025
Q4
$113K Buy
18,234
+4,600
+34% +$34.1K ﹤0.01% 2928
2025
Q3
$133K Hold
13,634
– – ﹤0.01% 2874
2025
Q2
$179K Buy
+13,634
New +$176K ﹤0.01% 2755
2025
Q1
– Sell
-20,700
Closed -$363K – 3060
2024
Q4
$363K Hold
20,700
– – ﹤0.01% 2423
2024
Q3
$251K Hold
20,700
– – ﹤0.01% 2550
2024
Q2
$133K Hold
20,700
– – ﹤0.01% 2699
2024
Q1
$126K Hold
20,700
– – ﹤0.01% 2739
2023
Q4
$125K Hold
20,700
– – ﹤0.01% 2677
2023
Q3
$134K Sell
20,700
-5,200
-20% -$29.1K ﹤0.01% 2602
2023
Q2
$113K Hold
25,900
– – ﹤0.01% 2676
2023
Q1
$93K Hold
25,900
– – ﹤0.01% 2703
2022
Q4
$96K Hold
25,900
– – ﹤0.01% 2725
2022
Q3
$98K Hold
25,900
– – ﹤0.01% 2734
2022
Q2
$113K Hold
25,900
– – ﹤0.01% 2733
2022
Q1
$123K Hold
25,900
– – ﹤0.01% 2815
2021
Q4
$164K Hold
25,900
– – ﹤0.01% 2803
2021
Q3
$175K Hold
25,900
– – ﹤0.01% 2754
2021
Q2
$190K Sell
25,900
-1,068
-4% -$8.72K ﹤0.01% 2739
2021
Q1
$252K Buy
26,968
+4,300
+19% +$40.1K ﹤0.01% 2620
2020
Q4
$211K Buy
22,668
+8,200
+57% +$92.1K ﹤0.01% 2542
2020
Q3
$175K Buy
+14,468
New +$196K ﹤0.01% 2446

Other funds holding LFVN

T. Rowe Price Associates's LFVN Position: Q2 2026 in Review

T. Rowe Price Associates reduced its LifeVantage (LFVN) stake by 29% in Q2 2026, selling an estimated $32.3K and leaving 12,900 shares worth $81K. The position accounts for ﹤0.01% of the portfolio, ranked #3167.

T. Rowe Price Associates first reported a position in LFVN in Q3 2020 and has held it in 23 quarters since. The position peaked at $363K in Q4 2024. 88 funds tracked by Wall St. Rank hold LFVN as of Q2 2026.

  • T. Rowe Price Associates held 12,900 shares of LifeVantage worth $81K as of Q2 2026.
  • T. Rowe Price Associates sold 5,334 LifeVantage shares in Q2 2026, an estimated $32.3K.
  • LifeVantage made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #3167 holding.
  • T. Rowe Price Associates first reported a position in LifeVantage in Q3 2020 and has held it in 23 quarters since.
  • T. Rowe Price Associates's LifeVantage position peaked at $363K in Q4 2024.
  • 88 funds tracked by Wall St. Rank held LifeVantage as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.